01 January 2005 :
Imatinib mesylate induced severe bone marrow aplasia in a patient with long duration of chronic myelogenous leukemia treated previously with busulphan and hydroxyurea
Case Rep Clin Pract Rev 2005; 6:332-336 :: ID: 440493
HTML version available soon